TASIGNA
NILOTINIB
Public price
8,59 MAD
Active substance
NILOTINIB
Laboratory
NOVARTIS PHARMA
What is this medicine?
Nilotinib is a kinase inhibitor used for the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML).
Verified summary
NILOTINIB, CAPSULE, 200 MG, BOITE DE 28
Common uses
Treatment of newly diagnosed Ph+ CML in chronic phase for adult and pediatric patients (1 year and older), as well as adult and pediatric patients with Ph+ CML who are resistant or intolerant to prior therapies such as imatinib or other tyrosine-kinase inhibitors.
Class
Kinase inhibitor
Laboratory
NOVARTIS PHARMA
Hospital price
8,43 MAD
Strength
200 MG
Form
CAPSULE
Presentation
BOITE DE 28
Commercial status
Retiré du Marché
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-01: 8,59 MAD